SCHEMBL13563752

SCHEMBL13563752

O=C(OC(c1cccc(F)c1)c1cccc(F)c1)C1C[N+]2(Cc3ccccc3)CCC1CC2

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CHRNB4 P30926 1/20 0.46
CHRNA3 P32297 1/20 0.46
CHRM3 P20309 7/20 0.42
CHRM2 P08172 6/20 0.42
CHRM1 P11229 4/20 0.39
CNR2 P34972 1/20 0.39
SLC6A9 P48067 1/20 0.37
SLC6A5 Q9Y345 1/20 0.37
IDO1 P14902 1/20 0.36
TDO2 P48775 1/20 0.36
MEN1 O00255 1/20 0.35
KMT2A Q03164 1/20 0.35
TACR1 P25103 1/20 0.35
CYP2D6 P10635 1/20 0.35
CYP2C9 P11712 1/20 0.35
ALOX15 P16050 1/20 0.35
CYP2C19 P33261 1/20 0.35
BCHE P06276 1/20 0.35
PPARG P37231 1/20 0.35
PPARA Q07869 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Bromide SCHEMBL13517218 0.99 CHRNB4 (0.46) CHRNB4CHRNA3CHRM3CHRM2CHRM1
SCHEMBL13563738 0.86 NPSR1 (0.40) CHRM3CHRM2CHRM1CNR2SLC6A9
Bromide SCHEMBL13517326 0.85 NPSR1 (0.42) CHRM3CHRM2CHRM1CNR2IDO1
SCHEMBL880903 0.84 CHRM3 (0.53) CHRNB4CHRNA3CHRM3CHRM2CHRM1
SCHEMBL230535 0.84 CHRM3 (0.53) CHRNB4CHRNA3CHRM3CHRM2CHRM1
SCHEMBL230536 0.84 CHRM3 (0.53) CHRNB4CHRNA3CHRM3CHRM2CHRM1
SCHEMBL13563746 0.84 CHRM3 (0.34) CHRM3CHRM2IDO1TDO2MEN1
Hydrochloric Acid SCHEMBL13735247 0.83 CHRM3 (0.34) CHRM3CHRM2IDO1TDO2MEN1
SCHEMBL13563745 0.82 BCHE (0.38) CHRM3CHRM2IDO1TDO2MEN1
SCHEMBL13563749 0.82 KAT6A (0.37) CHRM3CHRM2CHRM1IDO1TDO2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120276018-A1 ALKALOID ESTER AND CARBAMATE DERIVATIVES AND MEDICINAL COMPOSITIONS THEREOF CHIESI FARMACEUTICI S.P.A. (IT) 2012-11-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120276018-A1 ALKALOID ESTER AND CARBAMATE DERIVATIVES AND MEDICINAL COMPOSITIONS THEREOF CHRM3, BCHE, CHRM1 CHRNB4 147/4885CHRNA3 48/4885CHRM3 1/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.